Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2400199	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2024-08-08	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2400205	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2024-08-08	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2400203	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2024-08-08	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2400204	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2024-08-08	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2400201	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2024-08-08	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2400206	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2024-08-08	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2400200	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2024-08-08	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2400202	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2024-08-08	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CXSL2400368	四价重组诺如病毒疫苗（汉逊酵母）	Quadrivalent Recombinant Norovirus Vaccine(Hansenula Polymorpha)	Injection	Biological Products(1.1)	New Drug Application	2024-06-06	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CXSL2400367	四价重组诺如病毒疫苗（汉逊酵母）	Quadrivalent Recombinant Norovirus Vaccine(Hansenula Polymorpha)	Injection	Biological Products(1.1)	New Drug Application	2024-06-06	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CXSL2200535	长效重组人促红素注射液		Injection	Biological Products(3.3)	New Drug Application	2022-10-20	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CXSL2200533	长效重组人促红素注射液		Injection	Biological Products(3.3)	New Drug Application	2022-10-20	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CXSL2200534	长效重组人促红素注射液		Injection	Biological Products(3.3)	New Drug Application	2022-10-20	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CXSL2200531	长效重组人促红素注射液		Injection	Biological Products(3.3)	New Drug Application	2022-10-20	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CXSL2200532	长效重组人促红素注射液		Injection	Biological Products(3.3)	New Drug Application	2022-10-20	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CXSL2200530	长效重组人促红素注射液		Injection	Biological Products(3.3)	New Drug Application	2022-10-20	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2200036	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2022-02-11	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2101252	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2021-11-04	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2101255	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2021-11-04	NCPC Genetech BIOTECHNOLOGY Co Ltd	view
CYSB2101253	人促红素注射液	Human Erythropoietin	Injection	Biological Products	Supplementary Application	2021-11-04	NCPC Genetech BIOTECHNOLOGY Co Ltd	view